DE2611690A1
(de)
*
|
1976-03-19 |
1977-09-22 |
Goedecke Ag |
Cyclische sulfonyloxyimide
|
US4876279A
(en)
*
|
1986-05-05 |
1989-10-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
US4894476A
(en)
*
|
1988-05-02 |
1990-01-16 |
Warner-Lambert Company |
Gabapentin monohydrate and a process for producing the same
|
US4960931A
(en)
*
|
1988-05-02 |
1990-10-02 |
Warner-Lambert Company |
Gabapentin mohohydrate and a process for producing the same
|
YU162789A
(en)
*
|
1988-09-01 |
1990-12-31 |
Lonza Ag |
2-aza-4-(alcoxycarbonyl) spiro/4,5/decan-3-ones
|
DE3928183A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Lactamfreie cyclische aminosaeuren
|
DE3928184A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
|
US5319135A
(en)
*
|
1989-08-25 |
1994-06-07 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
US5132451A
(en)
*
|
1989-08-25 |
1992-07-21 |
Warner-Lambert Company |
Process for cyclic amino acid anticonvulsant compounds
|
MY106864A
(en)
*
|
1989-08-25 |
1995-08-30 |
Warner Lambert Co |
Improved process for cyclic amino acid anticonvulsant compounds.
|
DE3928182A1
(de)
*
|
1989-08-25 |
1991-02-28 |
Goedecke Ag |
Verfahren zur herstellung von gabapentin
|
US5157138A
(en)
*
|
1989-11-16 |
1992-10-20 |
Pfizer, Inc. |
Glutaric acid derivatives and preparation thereof
|
US5136091A
(en)
*
|
1989-11-16 |
1992-08-04 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl) cyclohexane acetic acid
|
GB8925933D0
(en)
*
|
1989-11-16 |
1990-01-04 |
Pfizer Ltd |
Glutaric acid derivatives and preparation thereof
|
US5149870A
(en)
*
|
1989-11-16 |
1992-09-22 |
Lonza Ltd. |
Process for the production of 1-(aminomethyl)cyclohexane acetic acid
|
US5260467A
(en)
*
|
1989-11-16 |
1993-11-09 |
Pfizer Inc. |
Glutaric acid derivatives and preparation thereof
|
FI905584A
(fi)
*
|
1989-11-16 |
1991-05-17 |
Lonza Ag |
Foerfarande foer framstaellning av 1-(aminometyl)cyklohexanaettikssyra.
|
US5084479A
(en)
*
|
1990-01-02 |
1992-01-28 |
Warner-Lambert Company |
Novel methods for treating neurodegenerative diseases
|
US5025035A
(en)
*
|
1990-10-12 |
1991-06-18 |
Warner-Lambert Company |
Method of treating depression
|
US5792796A
(en)
*
|
1994-07-27 |
1998-08-11 |
Warner-Lambert Company |
Methods for treating anxiety and panic
|
US5510381A
(en)
*
|
1995-05-15 |
1996-04-23 |
Warner-Lambert Company |
Method of treatment of mania and bipolar disorder
|
PL328432A1
(en)
*
|
1996-02-07 |
1999-02-01 |
Warner Lambert Co |
Novel cyclic amino acids as pharmaceutic agents
|
EP0888285B1
(en)
*
|
1996-03-14 |
2001-12-12 |
Warner-Lambert Company |
Novel bridged cyclic amino acids as pharmaceutical agents
|
HU224720B1
(en)
*
|
1996-03-14 |
2006-01-30 |
Warner Lambert Co |
Novel substituted cyclic amino acid derivatives use as pharmaceutical agents
|
USRE41920E1
(en)
|
1996-07-24 |
2010-11-09 |
Warner-Lambert Company Llc |
Isobutylgaba and its derivatives for the treatment of pain
|
JP2002514187A
(ja)
*
|
1996-10-23 |
2002-05-14 |
ワーナー―ランバート・コンパニー |
薬剤としての置換γ―アミノ酪酸
|
US6255526B1
(en)
|
1996-12-24 |
2001-07-03 |
Teva Pharmaceutical Industries Ltd. |
Preparation of gabapentin
|
IL119890A
(en)
*
|
1996-12-24 |
2002-03-10 |
Teva Pharma |
Gabapentin form iii and preparation of gabapentin form ii
|
HRP980342A2
(en)
*
|
1997-06-25 |
1999-02-28 |
Warner Lambert Co |
Anti-inflammatory method
|
US6329429B1
(en)
|
1997-06-25 |
2001-12-11 |
Warner-Lambert Company |
Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases
|
WO1999008667A2
(en)
|
1997-08-19 |
1999-02-25 |
Warner-Lambert Company |
Methods for treating physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants
|
ES2253825T3
(es)
*
|
1997-09-08 |
2006-06-01 |
Warner-Lambert Company Llc |
Composiciones analgesicas que comprenden compuestos antiepilepticos y procedimientos para usar las mismas.
|
WO1999018063A2
(en)
|
1997-10-07 |
1999-04-15 |
Warner-Lambert Company |
Process for preparing a cyclic amino acid anticonvulsant compound
|
AU755800B2
(en)
*
|
1997-10-27 |
2002-12-19 |
Warner-Lambert Company |
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
|
US6984659B2
(en)
*
|
1997-11-18 |
2006-01-10 |
Klinikum Der Albert-Ludwigs Universitaet |
2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
|
CU23028A3
(es)
|
1997-12-16 |
2005-02-23 |
Warner Lambert Co |
Aminas novedosas como agentes farmaceuticos.
|
BR9814287A
(pt)
|
1997-12-16 |
2000-10-03 |
Warner Lambert Co |
"4(3)-aminometil-(tio)piran 4(3) substituìdo ou derivados da piperidina (= análogos da gabapentina), sua preparação e seu uso no tratamento de desordens neurológicas"
|
TR200001795T2
(tr)
|
1997-12-16 |
2000-11-21 |
Warner-Lambert Company |
1-İkameli-1-Aminometil-sikloalkan türevleri (=Gabapentin analogları), bunların hazırlanması ve nörolojik bozuklukların tedavisinde kullanımı.
|
EP1047414A1
(en)
*
|
1998-01-23 |
2000-11-02 |
Warner-Lambert Company |
Gabapentin and its derivatives for the treatment of muscular and skeletal pain
|
EP0974351A3
(en)
*
|
1998-04-24 |
2000-12-13 |
Jouveinal |
Medicament for preventing and treating gastrointestinal damage
|
CN100337687C
(zh)
*
|
1998-05-15 |
2007-09-19 |
沃尼尔·朗伯公司 |
含有γ-氨基丁酸衍生物的固体组合物及其制备方法
|
DE69918977T2
(de)
|
1998-05-15 |
2005-07-28 |
Warner-Lambert Co. Llc |
Aminosäure-stabilisierte gabapentin und pregabalin zubereitungen und verfahren zu ihrer herstellung
|
ES2137137B1
(es)
*
|
1998-05-25 |
2000-08-16 |
Medichem Sa |
Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
|
US6316638B1
(en)
|
1998-05-26 |
2001-11-13 |
Warner-Lambert Company |
Conformationally constrained amino acid compounds having affinity for the alpha2delta subunit of a calcium channel
|
ITMI981535A1
(it)
*
|
1998-07-03 |
2000-01-03 |
Zambon Spa |
Processo per la preparazione di gabapentina
|
US20030045500A1
(en)
*
|
1998-07-09 |
2003-03-06 |
Leslie Magnus |
Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles
|
FR2781793B1
(fr)
|
1998-08-03 |
2001-07-20 |
Prographarm Lab |
Procede de fabrication de granules de gabapentine enrobes
|
HU225502B1
(en)
*
|
1998-12-29 |
2007-01-29 |
Richter Gedeon Vegyeszet |
Process for producing 1-(amino-metyl)-cyclohexene-acetic-acid and intermediates
|
IT1311984B1
(it)
|
1999-03-26 |
2002-03-22 |
Bioindustria Lab Italiano Medi |
Procedimento per la preparzione di gabapentin.
|
DE60022333T2
(de)
*
|
1999-04-09 |
2006-07-06 |
Euro-Celtique S.A. |
Natrium kanalblocker zusammensetzungen und deren verwendung
|
BR0011039A
(pt)
*
|
1999-05-28 |
2002-02-26 |
Warner Lambert Co |
Análogos de gaba substituìdos com 3-heteroarilalquila
|
US6710190B1
(en)
|
1999-05-28 |
2004-03-23 |
Warner-Lambert Company |
3-heteroarylalkyl substituted gaba analogs
|
RS50352B
(sr)
*
|
1999-06-10 |
2009-11-10 |
Warner-Lambert Company Llc., |
Monosupstituisane 3-propil gama-aminobuterne kiseline
|
US7164034B2
(en)
*
|
1999-06-10 |
2007-01-16 |
Pfizer Inc. |
Alpha2delta ligands for fibromyalgia and other disorders
|
US20080207755A1
(en)
*
|
2000-05-31 |
2008-08-28 |
Pfizer Inc |
Alpha 2 Delta Ligands For Fibromyalgia and Other Disorders
|
US6294198B1
(en)
|
1999-08-24 |
2001-09-25 |
Purepac Pharmaceutical Co. |
Pharmaceutical tablet formulation containing gabapentin with improved physical and chemical characteristics and method of making the same
|
HN2000000224A
(es)
|
1999-10-20 |
2001-04-11 |
Warner Lambert Co |
Aminoacidos biciclicos como agentes farmaceuticos
|
GB2362646A
(en)
*
|
2000-05-26 |
2001-11-28 |
Warner Lambert Co |
Cyclic amino acid derivatives useful as pharmaceutical agents
|
EP1294364A4
(en)
*
|
2000-06-16 |
2004-06-16 |
Teva Pharma |
STABLE GABAPENTINE WITH A PH WITHIN A CONTROLLED AREA
|
DE60101476T2
(de)
|
2000-06-16 |
2004-05-27 |
Teva Pharmaceutical Industries Ltd. |
Stabiles gabapentin, das mehr als 20 ppm chlor enthält
|
EP1384473A1
(en)
*
|
2000-06-16 |
2004-01-28 |
Teva Pharmaceutical Industries Ltd. |
Stable gabapentin containing more than 20 ppm of chlorine ion
|
CZ20024110A3
(cs)
*
|
2000-06-26 |
2003-10-15 |
Warner-Lambert Company |
Léčivo pro léčení poruch spánku
|
GB2364049A
(en)
*
|
2000-06-28 |
2002-01-16 |
Warner Lambert Co |
Cyclic ketones and their use in the synthesis of amino acids
|
DE50108104D1
(de)
*
|
2000-09-14 |
2005-12-22 |
Gruenenthal Gmbh |
Beta-thio-aminosäuren
|
US6900192B2
(en)
*
|
2000-10-06 |
2005-05-31 |
Xenoport, Inc. |
Bile-acid conjugates for providing sustained systemic concentrations of drugs
|
AU2002211863A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Xenoport, Inc. |
Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration
|
US6620829B2
(en)
*
|
2000-10-17 |
2003-09-16 |
Warner-Lambert Company |
Method of treating noninflammatory cartilage damage
|
IT1319234B1
(it)
*
|
2000-10-23 |
2003-09-26 |
Zambon Spa |
Processo di preparazione di gabapentina.
|
GB2368579A
(en)
*
|
2000-10-31 |
2002-05-08 |
Parke Davis & Co Ltd |
Azole pharmaceutical agents
|
HUP0303352A3
(en)
|
2000-11-02 |
2005-04-28 |
Teva Pharma |
Improved process for production of gabapentin intermediate
|
AU2002215160A1
(en)
*
|
2000-11-30 |
2002-06-11 |
Pfizer Products Inc. |
Combination of gaba agonists and aldose reductase inhibitors
|
KR20030059290A
(ko)
*
|
2000-11-30 |
2003-07-07 |
화이자 프로덕츠 인코포레이티드 |
Gaba 작용제 및 소르비톨 데하이드로게나제 억제제의혼합물
|
IT1319674B1
(it)
*
|
2000-12-01 |
2003-10-23 |
Erregierre Spa |
Processo per la preparazione dell'acido1-(aminometil)cicloesanacetico.
|
EP1373186A1
(en)
*
|
2001-03-16 |
2004-01-02 |
Solchem Italiana S.p.A |
A process for the preparation of cyclic amino acids
|
ITMI20011132A1
(it)
|
2001-05-29 |
2002-11-29 |
Procos Spa |
Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico
|
US6818787B2
(en)
*
|
2001-06-11 |
2004-11-16 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
ATE380029T1
(de)
*
|
2001-06-11 |
2007-12-15 |
Xenoport Inc |
Prodrugs von gaba-analoga, zusammensetzungen und ihre verwendungszwecke
|
AU2002345638A1
(en)
*
|
2001-06-11 |
2002-12-23 |
Xenoport, Inc. |
Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
|
US8048917B2
(en)
*
|
2005-04-06 |
2011-11-01 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
US7232924B2
(en)
*
|
2001-06-11 |
2007-06-19 |
Xenoport, Inc. |
Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
|
US7186855B2
(en)
|
2001-06-11 |
2007-03-06 |
Xenoport, Inc. |
Prodrugs of GABA analogs, compositions and uses thereof
|
IL144066A0
(en)
*
|
2001-06-28 |
2002-04-21 |
Bromine Compounds Ltd |
Process for the preparation of 1,1-cyclohexane diacetic monoamide
|
ITMI20011772A1
(it)
|
2001-08-10 |
2003-02-10 |
A M S A Anonima Materie Sint E |
Processo per la preparazione della 2,5-bis-(2,2,2-trifluoroetossi)-n-(2-piperidilmetil)-benzamide(flecainide)
|
RU2295337C2
(ru)
|
2001-09-03 |
2007-03-20 |
Ньюрон Фармасьютикалс Спа |
Фармацевтическая композиция, содержащая габапентин или его аналог и альфа-аминоамид, и ее применение в качестве анальгетика
|
US6800782B2
(en)
*
|
2001-10-09 |
2004-10-05 |
Warner-Lambert Co. |
Anhydrous crystalline forms of gabapentin
|
TWI312285B
(en)
|
2001-10-25 |
2009-07-21 |
Depomed Inc |
Methods of treatment using a gastric retained gabapentin dosage
|
US20060159743A1
(en)
*
|
2001-10-25 |
2006-07-20 |
Depomed, Inc. |
Methods of treating non-nociceptive pain states with gastric retentive gabapentin
|
US20070184104A1
(en)
*
|
2001-10-25 |
2007-08-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
US7612112B2
(en)
|
2001-10-25 |
2009-11-03 |
Depomed, Inc. |
Methods of treatment using a gastric retained gabapentin dosage
|
ITMI20012750A1
(it)
|
2001-12-21 |
2003-06-21 |
Procos Spa |
Processo per la produzione dell'acido 1-(amminometil)-cicloesil-acetico in forma pura
|
US20030119908A1
(en)
*
|
2001-12-21 |
2003-06-26 |
Zambon Group S.P.A. |
Stable gabapentin compositions
|
PL371944A1
(en)
*
|
2002-01-31 |
2005-07-11 |
Warner-Lambert Company Llc |
Alpha 2 delta ligands to treat tinnitus
|
US6682759B2
(en)
|
2002-02-01 |
2004-01-27 |
Depomed, Inc. |
Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
|
US6927036B2
(en)
*
|
2002-02-19 |
2005-08-09 |
Xero Port, Inc. |
Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
|
US7026351B2
(en)
*
|
2002-03-20 |
2006-04-11 |
Xenoport, Inc. |
Cyclic 1-(acyloxy)-alkyl prodrugs of GABA analogs, compositions and uses thereof
|
EP1494996A1
(en)
*
|
2002-04-16 |
2005-01-12 |
Taro Pharmaceutical Industries Limited |
Process for preparing gabapentin
|
US20050153928A1
(en)
*
|
2002-05-07 |
2005-07-14 |
Holick Michael F. |
Conjugates comprising a central nervous system-active drug linked to glucuronic acid or glucosamine through an amide bond and uses thereof
|
US7183259B2
(en)
*
|
2002-05-17 |
2007-02-27 |
Xenoport |
Amino acid conjugates providing for sustained systemic concentrations of GABA analogues
|
CN1678298A
(zh)
*
|
2002-06-27 |
2005-10-05 |
沃纳-兰伯特公司 |
α2δ配体如加巴喷丁或普瑞巴林用于治疗注意力缺陷的过度反应症的用途
|
CA2395931A1
(en)
*
|
2002-08-07 |
2004-02-07 |
Bernard Charles Sherman |
Solid compositions comprising gabapentin having improved stability
|
US7053122B2
(en)
*
|
2002-08-09 |
2006-05-30 |
Pfizer Inc |
Therapeutic use of aryl amino acid derivatives
|
US20040092591A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Blakemore David Clive |
Therapeutic use of fused bicyclic or tricyclic amino acids
|
US7419981B2
(en)
*
|
2002-08-15 |
2008-09-02 |
Pfizer Inc. |
Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
|
US20040092522A1
(en)
*
|
2002-08-15 |
2004-05-13 |
Field Mark John |
Synergistic combinations
|
US20040092498A1
(en)
*
|
2002-08-16 |
2004-05-13 |
David Blakemore |
Substituted glycine derivatives for use as medicaments
|
ITMI20022071A1
(it)
*
|
2002-10-01 |
2004-04-02 |
Erregierre Spa |
Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
|
US7659305B2
(en)
*
|
2002-10-31 |
2010-02-09 |
Pfizer Inc. |
Therapeutic proline derivatives
|
DE60230552D1
(de)
*
|
2002-11-18 |
2009-02-05 |
Nicholas Piramal India Ltd |
Verbessertes verfahren zur herstellung von gabapentin
|
ES2334119T3
(es)
*
|
2002-11-20 |
2010-03-05 |
Hikal Ltd. |
Procedimiento mejorado para la fabricacion de gabalactama.
|
AU2003297927A1
(en)
*
|
2002-12-11 |
2004-06-30 |
Xenoport, Inc. |
Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
|
WO2004053192A1
(en)
*
|
2002-12-11 |
2004-06-24 |
Xenoport, Inc. |
Orally administered dosage forms of fused gaba analog prodrugs having reduced toxicity
|
CA2451267A1
(en)
*
|
2002-12-13 |
2004-06-13 |
Warner-Lambert Company Llc |
Pharmaceutical uses for alpha2delta ligands
|
MXPA05006209A
(es)
*
|
2002-12-13 |
2005-08-19 |
Warner Lambert Co |
Pregabalina y sus derivados para el tratamiento de fibromialgia y otros trastornos relacionados.
|
KR20050085636A
(ko)
|
2002-12-13 |
2005-08-29 |
워너-램버트 캄파니 엘엘씨 |
섬유근육통 및 기타 질환의 치료를 위한 프레가발린 유도체
|
WO2004054564A1
(en)
*
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Gabapentin analogues for fibromyalgia and other related disorders
|
US20040180958A1
(en)
*
|
2002-12-13 |
2004-09-16 |
Taylor Charles Price |
Method of treatment
|
CA2509605C
(en)
|
2002-12-13 |
2010-10-05 |
Warner-Lambert Company Llc |
Alpha-2-delta ligand to treat lower urinary tract symptoms
|
GB0301143D0
(en)
*
|
2003-01-17 |
2003-02-19 |
Amedis Pharm Ltd |
Compounds and their use
|
EP1592661A2
(en)
*
|
2003-01-22 |
2005-11-09 |
Warner-Lambert Company LLC |
Cyclopropyl beta-amino acid derivatives
|
BRPI0408110A
(pt)
*
|
2003-03-07 |
2006-03-01 |
Warner Lambert Co |
derivados de beta-aminoácido substituìdos com tetrazol e oxadiazolona
|
EP1628656B1
(en)
*
|
2003-03-25 |
2008-10-15 |
Kiel Laboratories, Inc. |
Gabapentin tannate in liquid and/or semi-solid dosage forms
|
WO2004093866A1
(en)
*
|
2003-03-25 |
2004-11-04 |
Kiel Laboratories, Inc. |
Process for preparing phenolic acid salts of gabapentin
|
EP1622603A4
(en)
*
|
2003-03-25 |
2010-03-24 |
Kiel Lab Inc |
GABAPENTINIC PHENOLIC ACID SALTS IN SOLID DOSAGE FORMS AND METHODS OF USE
|
WO2004089289A2
(en)
*
|
2003-03-31 |
2004-10-21 |
Xenoport, Inc. |
Treating or preventing hot flashes using prodrugs of gaba analogs
|
US20040214893A1
(en)
*
|
2003-04-11 |
2004-10-28 |
Matthew Peterson |
Gabapentin compositions
|
ITMI20030825A1
(it)
*
|
2003-04-18 |
2004-10-19 |
Farchemia Srl |
Procedimento per la preparazione di gabapentin esente da
|
EP1615875A2
(en)
*
|
2003-04-21 |
2006-01-18 |
Matrix Laboratories Limited |
Process for the preparation of gabapentin form-ii
|
WO2004100992A2
(en)
*
|
2003-05-16 |
2004-11-25 |
Pfizer Products Inc. |
Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
|
MXPA05013754A
(es)
*
|
2003-06-19 |
2006-03-08 |
Pfizer Prod Inc |
Una preparacion biocatalitica del acido 1-cianociclohexanoacetico.
|
US7169812B2
(en)
*
|
2003-07-01 |
2007-01-30 |
Medtronic, Inc. |
Process for producing injectable gabapentin compositions
|
EP1680125A1
(en)
*
|
2003-07-02 |
2006-07-19 |
Warner-Lambert Company LLC |
Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
|
US20050013863A1
(en)
|
2003-07-18 |
2005-01-20 |
Depomed, Inc., A Corporation Of The State Of California |
Dual drug dosage forms with improved separation of drugs
|
WO2005046566A2
(en)
*
|
2003-08-04 |
2005-05-26 |
Sun Pharmaceutical Industries Limited |
Stable gabapentin containing composition
|
US20050043407A1
(en)
*
|
2003-08-22 |
2005-02-24 |
Pfizer Inc |
Pharmaceutical composition for the prevention and treatment of addiction in a mammal
|
KR20060119971A
(ko)
*
|
2003-09-11 |
2006-11-24 |
제노포트 인코포레이티드 |
Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방
|
WO2005025563A1
(en)
*
|
2003-09-12 |
2005-03-24 |
Warner-Lambert Company Llc |
Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders
|
RU2320369C2
(ru)
*
|
2003-09-12 |
2008-03-27 |
Пфайзер Инк. |
Комбинации, содержащие альфа-2-дельта лиганды и ингибиторы обратного захвата серотонина/норадреналина
|
MXPA06003043A
(es)
*
|
2003-09-17 |
2006-05-31 |
Xenoport Inc |
Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
|
BRPI0415288B8
(pt)
|
2003-10-14 |
2021-05-25 |
Xenoport Inc |
composição farmacêutica compreendendo o ácido 1-{[(a- isobutanoiloxietoxi) carbonil] aminometil}- 1-ciclo- hexano acético cristalino
|
ITMI20032165A1
(it)
*
|
2003-11-11 |
2005-05-12 |
Zambon Spa |
Processo di preparazione di gabapentina
|
DK1691811T3
(da)
|
2003-12-11 |
2014-10-20 |
Sunovion Pharmaceuticals Inc |
Kombination af et sedativ og en neurotransmittermodulator og fremgangsmåder til forbedring af søvnkvaliteten og behandling af depression
|
BRPI0507190A
(pt)
*
|
2004-01-29 |
2007-06-26 |
Pfizer Prod Inc |
combinação de moduladores do ácido gama-aminobutìrico e antagonistas de 5-ht1b receptores
|
US20050187295A1
(en)
*
|
2004-02-19 |
2005-08-25 |
Surendra Kalyan |
Processes for the preparation of gabapentin
|
EP1763503A1
(en)
*
|
2004-03-17 |
2007-03-21 |
Hikal Limited |
4-t-butylgabapentin and its synthesis
|
ITMI20040579A1
(it)
*
|
2004-03-25 |
2004-06-25 |
Zambon Spa |
Processo di preparazione di gabapentina
|
EP1737473A4
(en)
*
|
2004-04-19 |
2009-08-26 |
Noven Therapeutics Llc |
COMBINATIONS OF LITHIUM AND USES THEREOF
|
EP1763354A2
(en)
*
|
2004-06-09 |
2007-03-21 |
Pfizer Limited |
Use of reboxetine for the treatment of pain
|
GB0416228D0
(en)
*
|
2004-07-20 |
2004-08-25 |
Sandoz Ind Products S A |
Process for the preparation of gabapentin
|
GB0419849D0
(en)
*
|
2004-09-07 |
2004-10-13 |
Pfizer Ltd |
Pharmaceutical combination
|
RU2391973C2
(ru)
*
|
2004-09-10 |
2010-06-20 |
Ньюрон Фармасьютикалс С.П.А. |
Применение (галобензилокси)бензиламино-пропанамидов для производства лекарственных средств, действующих как селективные модуляторы натриевых и/или кальциевых каналов
|
MX2007005306A
(es)
*
|
2004-11-04 |
2007-06-11 |
Xenoport Inc |
Formas de dosis oral de liberacion sostenida de la prodroga gabapentina.
|
EP2258359A3
(en)
|
2005-08-26 |
2011-04-06 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation with sabcomelin
|
CA2620333A1
(en)
|
2005-08-26 |
2007-03-01 |
Braincells, Inc. |
Neurogenesis by muscarinic receptor modulation
|
US8378117B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
US8378096B2
(en)
*
|
2005-09-23 |
2013-02-19 |
Janssen Pharmaceutica N.V. |
Hexahydro-cycloheptapyrazole cannabinoid modulators
|
PT1937259E
(pt)
*
|
2005-09-23 |
2012-01-17 |
Janssen Pharmaceutica Nv |
Moduladores canabinóides de hexahidro-cicloheptapirazol
|
KR20080066924A
(ko)
*
|
2005-09-23 |
2008-07-17 |
얀센 파마슈티카 엔.브이. |
헥사하이드로 사이클로옥틸 피라졸 카나비노이드모듈레이터
|
US7825151B2
(en)
*
|
2005-09-23 |
2010-11-02 |
Janssen Pharmaceutica Nv |
Hexahydro-cyclooctyl pyrazole cannabinoid modulators
|
CA2623803A1
(en)
|
2005-09-23 |
2007-03-29 |
Janssen Pharmaceutica N.V. |
Tetrahydro-cyclopentyl pyrazole cannabinoid modulators
|
AU2006304787A1
(en)
|
2005-10-21 |
2007-04-26 |
Braincells, Inc. |
Modulation of neurogenesis by PDE inhibition
|
WO2007053596A1
(en)
*
|
2005-10-31 |
2007-05-10 |
Braincells, Inc. |
Gaba receptor mediated modulation of neurogenesis
|
US20070117858A1
(en)
*
|
2005-11-23 |
2007-05-24 |
Mingde Xia |
Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators
|
US20090176882A1
(en)
|
2008-12-09 |
2009-07-09 |
Depomed, Inc. |
Gastric retentive gabapentin dosage forms and methods for using same
|
WO2007092456A2
(en)
*
|
2006-02-03 |
2007-08-16 |
Rolls-Royce Corporation |
Gas turbine engine fuel system with fuel metering valve
|
EP1820502A1
(en)
|
2006-02-10 |
2007-08-22 |
Laboratorios Del Dr. Esteve, S.A. |
Active substance combination comprising azolylcarbinol compounds
|
WO2007095513A1
(en)
*
|
2006-02-14 |
2007-08-23 |
Janssen Pharmaceutica, Nv |
Tetrahydr0-2h-indaz0le derivatives for use as cannabinoid modulators
|
WO2007102058A1
(en)
*
|
2006-03-06 |
2007-09-13 |
Pfizer Products Inc. |
Alpha-2-delta ligands for non-restorative sleep
|
US20100216734A1
(en)
|
2006-03-08 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis by nootropic agents
|
WO2007112402A1
(en)
*
|
2006-03-27 |
2007-10-04 |
Janssen Pharmaceutica N.V. |
Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
|
US20070254911A1
(en)
*
|
2006-03-27 |
2007-11-01 |
Mingde Xia |
Tetrahydro-Pyrazolo[3,4-c]Pyridine Cannabinoid Modulators
|
US7678808B2
(en)
|
2006-05-09 |
2010-03-16 |
Braincells, Inc. |
5 HT receptor mediated neurogenesis
|
EP2021000A2
(en)
|
2006-05-09 |
2009-02-11 |
Braincells, Inc. |
Neurogenesis by modulating angiotensin
|
US7442834B2
(en)
*
|
2006-06-12 |
2008-10-28 |
Zhejiang Chiral Medicine Chemicals Co., Ltd. |
Process suitable for industrial scale production of gabapentin
|
ES2439242T3
(es)
*
|
2006-06-30 |
2014-01-22 |
Zach System S.P.A. |
Procedimiento para preparar gabapentina
|
AU2007292848A1
(en)
|
2006-09-08 |
2008-03-13 |
Braincells, Inc. |
Combinations containing a 4-acylaminopyridine derivative
|
US20100184806A1
(en)
|
2006-09-19 |
2010-07-22 |
Braincells, Inc. |
Modulation of neurogenesis by ppar agents
|
WO2008073257A1
(en)
*
|
2006-12-08 |
2008-06-19 |
Xenoport, Inc. |
Use of prodrugs of gaba analogs for treating diseases
|
EA017171B1
(ru)
|
2006-12-22 |
2012-10-30 |
Рекордати Айерленд Лимитед |
КОМБИНИРОВАННАЯ ТЕРАПИЯ ЗАБОЛЕВАНИЙ НИЖНИХ МОЧЕВЫВОДЯЩИХ ПУТЕЙ С ИСПОЛЬЗОВАНИЕМ ЛИГАНДОВ αδ И НЕСТЕРОИДНЫХ ПРОТИВОВОСПАЛИТЕЛЬНЫХ ПРЕПАРАТОВ (НПВП)
|
CA2679741A1
(en)
*
|
2007-03-15 |
2008-09-18 |
Sun Pharma Advanced Research Company Ltd. |
Novel prodrugs
|
TW200908957A
(en)
*
|
2007-06-15 |
2009-03-01 |
Xenoport Inc |
Use of prodrugs of GABA analogs, antispasticity agents, and prodrugs of GABAB receptor agonists for treating spasticity
|
US7943653B2
(en)
*
|
2007-08-13 |
2011-05-17 |
Janssen Pharmaceutica N.V. |
Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators
|
US20090062392A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched gabapentin
|
TW200936123A
(en)
*
|
2007-11-06 |
2009-09-01 |
Xenoport Inc |
Use of prodrugs of GABAb agonists for treating neuropathic and musculoskeletal pain
|
US7868043B2
(en)
|
2008-01-25 |
2011-01-11 |
Xenoport, Inc. |
Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use
|
JP5291123B2
(ja)
*
|
2008-01-25 |
2013-09-18 |
ゼノポート,インコーポレイティド |
(3s)−アミノメチル−5−ヘキサン酸プロドラッグの結晶形態及びその使用
|
EP2250148B1
(en)
*
|
2008-01-25 |
2016-08-17 |
XenoPort, Inc. |
Crystalline form of calcium-salts of (3s)-aminomethyl-5-methyl-hexanoic acids and methods of use
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
US20100190752A1
(en)
*
|
2008-09-05 |
2010-07-29 |
Gruenenthal Gmbh |
Pharmaceutical Combination
|
WO2010042759A2
(en)
|
2008-10-08 |
2010-04-15 |
Kyphia Pharmaceuticals Inc |
Gaba conjugates and methods of use thereof
|
US9192681B2
(en)
|
2009-02-24 |
2015-11-24 |
Nektar Therapeutics |
Oligomer-amino acid conjugates
|
US20100216805A1
(en)
|
2009-02-25 |
2010-08-26 |
Braincells, Inc. |
Modulation of neurogenesis using d-cycloserine combinations
|
US20110130454A1
(en)
*
|
2009-11-24 |
2011-06-02 |
Xenoport, Inc. |
Prodrugs of gamma-amino acid, alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
US20110124705A1
(en)
*
|
2009-11-24 |
2011-05-26 |
Xenoport, Inc. |
Prodrugs of alpha-2-delta ligands, pharmaceutical compositions and uses thereof
|
WO2011071995A2
(en)
|
2009-12-08 |
2011-06-16 |
Case Western Reserve University |
Compounds and methods of treating ocular disorders
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
EP2368872A1
(en)
|
2010-03-25 |
2011-09-28 |
Serichim S.r.l. |
Process for the preparation of Gabapentin
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
IN2012MN02923A
(US20100012521A1-20100121-C00001.png)
|
2010-06-01 |
2015-06-05 |
Rubicon Res Private Ltd |
|
US8431739B2
(en)
|
2010-06-14 |
2013-04-30 |
Divi's Laboratories, Ltd. |
Process for the preparation of gabapentin
|
WO2012015027A1
(ja)
|
2010-07-30 |
2012-02-02 |
東レ株式会社 |
神経障害性疼痛の治療剤又は予防剤
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
JP2013216580A
(ja)
*
|
2010-08-06 |
2013-10-24 |
Kyorin Pharmaceutical Co Ltd |
ビシクロ[2.2.2]オクチルアミン誘導体の製造方法
|
EP2524694A1
(en)
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
EP2530072A1
(en)
|
2011-06-03 |
2012-12-05 |
Lacer, S.A. |
New compounds, synthesis and use thereof in the treatment of pain
|
US9066853B2
(en)
|
2013-01-15 |
2015-06-30 |
Warsaw Orthopedic, Inc. |
Clonidine compounds in a biodegradable fiber
|
ITMI20131757A1
(it)
|
2013-10-22 |
2015-04-23 |
Zach System Spa |
Processo di preparazione di gabapentina
|
CA2928559C
(en)
|
2013-11-01 |
2022-08-30 |
Glytech, Inc. |
Method of manufacturing d- or l-form amino acid derivative possessing a thiol group
|
SG11201604480PA
(en)
|
2013-12-17 |
2016-07-28 |
Esteve Labor Dr |
SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITORS (SNRIs) AND SIGMA RECEPTOR LIGANDS COMBINATIONS
|
CN105873580B
(zh)
|
2013-12-17 |
2020-08-25 |
埃斯蒂维制药有限公司 |
加巴喷丁类化合物与σ受体配体的组合物
|
EP2923694B1
(en)
|
2014-03-27 |
2018-11-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Oral liquid pharmaceutical solution of gabapentin
|
DK3554490T3
(da)
|
2016-12-16 |
2022-02-28 |
Idorsia Pharmaceuticals Ltd |
Farmaceutisk kombination omfattende en calciumkanalblokker type T
|
EP3818981B1
(en)
|
2018-07-04 |
2024-02-21 |
Amézcua Amézcua, Federico |
Synergic pharmaceutical composition of the active enantiomer (s)-ketorolac and gabapentin for the treatment of neuropathic pain
|
US10399926B1
(en)
|
2018-08-01 |
2019-09-03 |
Divi's Laboratories Ltd. |
Process for the preparation of gabapentin
|
WO2020074944A1
(en)
|
2018-10-11 |
2020-04-16 |
Sanifit Therapeutics S.A. |
Inositol phosphates for the treatment of ectopic calcification
|
EP4049679A4
(en)
|
2019-10-25 |
2023-11-01 |
Kyoto University |
PREVENTIVE OR THERAPEUTIC AGAINST TAUOPATHY
|
EP4015494A1
(en)
|
2020-12-15 |
2022-06-22 |
Sanifit Therapeutics S.A. |
Processes for the preparation of soluble salts of inositol phosphates
|